News Focus
News Focus
icon url

pennytiger

01/13/20 9:35 AM

#209233 RE: 4toSchool #209231

I mentioned that awhile back, a gross incompetence that cost this company millions, and yet AW did not think it was good idea sign the deal with CVS, but instead opted to pile on more dilution!

So he screwed the shareholders twice!

icon url

art2426

01/13/20 12:35 PM

#209256 RE: 4toSchool #209231

>>>I guess it's okay because Kelly "ill-gotten gain" Whelan lent BIEL money to keep operating, lol. Of course the equity dilution of this error cost shareholders dearly.<<<

Scary thought, that since the Whelans make a boatload of money from loaning funds to company, that they could care less if this company makes money or not. If company is successful, then no need for financing and no need for IBEX. Thus an end to their self serving money maker. Hopefully after heisting enough shares at such a discount, they eventually would like to see a nice gain on all those scamming shares they accumulated that hurt all other stockholders. Then maybe actually encouraging company success to maximize their wealth from all those shares. Maybe then, all us peon stockholders could profit from a stock price rise.
icon url

Simpsonly

01/13/20 3:08 PM

#209269 RE: 4toSchool #209231

I've asked the following question twice 4tS regarding the claims that sales are flourishing in the UK because ActiPatch is included on the national insurance coverage of the NHS for sales generated by a Physician prescription......

"What were the BIEL sales last year in the UK, since it is free on subscription by Physicians under the NHS system?"

So what if ActiPatch is covered. If Physicians are not aware of ActiPatch, they won't write it. Similar to claims that B.Braun sales are robust too. B.Braun has been inactive in generating ActiPatch sales for 4 years and never did much. Source? Andrew Whelan 18 months ago, "We haven't done anything with Braun for a couple of years." Hype and bunk pre-Keith Nalepka still being sold by misleaders.